磷酸化丝裂原活化蛋白激酶激酶5抗体
MAP2K5(phospho S129); Dual specificity mitogen activated protein kinase kinase 5; MAP kinase kinase 5; MAP kinase kinase MEK5b; MAP2K5; MAPK/ERK kinase 5; MAPKK5; PRKMK5; EC 2.7.12.2.
苯乙醇胺甲基转移酶抗体
Noradrenaline N-methyltransferase; PENT; Phenylethanolamine N-methyltransferase; PNMTase; PNMT_HUMAN.
死亡效应结构域蛋白1抗体
CASP8IP1; Death effector domain containing; Death effector domain containing protein; Death effector domain containing testicular molecule; DEDD 1; DEDD1; DEDPro 1; DEDPro1; DEFT; FLDED 1; FLDED1; KE
γ氨基丁酸受体相关蛋白样1抗体
APG8 like; APG8L; ATG8; ATG8L; Early estrogen regulated protein; GABA; GABA(A) receptor associated protein like 1; GABARAPL1; Gamma aminobutyric acid receptor associated protein like 1; GEC 1; GEC1; G
核酸敏感元件结合蛋白1
BP 8; CBF-A; YB1; CCAAT binding transcription factor I subunit A; YBX1; CCAAT-binding transcription factor I subunit A; CSDA2; CSDB; DBPB; DNA binding protein B; DNA-binding protein B; EFI-A; Enhancer
Anti-PRIM1 Polyclonal Antibody
Anti-PRIM1 Polyclonal Antibody应用 WB IHC 稀释比例 WB 1:5000-8000. IHC 1:100-300. 交叉反应 Human
Anti-HYAL1 Polyclonal Antibody
Anti-HYAL1 Polyclonal Antibody 应用 IHC 稀释比例 IHC 1:50-200. 交叉反应 Human